(Reuters) - Sarepta Therapeutics' shares jumped 60 percent on Tuesday after promising results from a gene therapy study positioned the specialty drugmaker as a potential leader in the market for Duchenne muscular dystrophy (DMD) treatments.
NEW YORK (Reuters) - The Trump administration on Tuesday issued a finalized rule that will enable millions of Americans to buy skimpy health insurance plans that do not comply with key Obamacare coverage requirements, marking its latest effort to chip away at the healthcare law.
GENEVA (Reuters) - Botswana notified its trading partners on Tuesday of a suspected outbreak of foot and mouth disease in cattle in its Ngamiland district and said it had banned meat exports from the area, adding there was no impact on exports to the European Union.
STOCKTON, Calif. (Reuters) - California prison inmate Richard Arriola does not remember the digestion problems that drove him to the doctor on a recent morning, or details of the conviction for child molestation that sent him to prison at age 88.
DUBAI (Reuters) - The United Arab Emirates (UAE) has banned the import of domestic and wild live birds, as well as their meat and meat products from Russia after a bird flu outbreak, state news agency WAM reported on Tuesday.
NEW YORK (Reuters) - Yum Brand Inc's Pizza Hut chain will fully phase out chickens raised with certain antibiotics in its U.S. restaurants by 2022, in the latest push by a major restaurant chain to follow healthier food practices.
ZURICH/LONDON (Reuters) - Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine (FMI) , raising its bet on the U.S. genomic profiling group's ability to personalize cancer care.
LONDON (Reuters) - Britain said on Tuesday it had no intention of legalizing cannabis after a former leader of Prime Minister Theresa May's party said the government had "irreversibly lost" the battle to drive the drug off the streets.
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG has agreed to pay $137 per share to buy the rest of Foundation Medicine (FMI) , a $2.4 billion transaction that values the U.S. genomic profiling group at $5.3 billion, the partners said on Tuesday.
(Reuters Health) - Obese people with knee osteoarthritis, a painful joint disease, may find greater symptom relief when they lose larger amounts of weight than when they shed fewer pounds, a recent study suggests.
(Reuters Health) - When terminally ill Americans receive experimental medicines through so-called "compassionate use" programs, they typically only get these drugs after extensive tests for safety and effectiveness, a U.S. study suggests.
XYLOKASTRO, Greece (Reuters) - Konstantinos Syros turned to cannabis 26 years ago after a motorcycle accident left him with deformed arm and debilitating pain that conventional treatments could not assuage. For years he had to buy it illegally. Now, he plans to grow it himself.
LONDON (Reuters) - The British government will look into possible changes to rules on the use of cannabis-based medicines, a minister said on Monday, after an epileptic boy whose medication was confiscated was hospitalized.
ZURICH (Reuters) - A drug being co-developed by Roche to treat spinal muscular atrophy (SMA) helped improve development scores in babies with the genetic disease, a study released on Monday showed, as the race heats up for therapies destined to be among the drug industry's most expensive.
LONDON (Reuters) - British Prime Minister Theresa May's pledge to increase healthcare funding by 20 billion pounds ($26.51 billion) won broad approval from her cabinet of top ministers on Monday, her spokesman said.